Moggi G, De Luca Brunori I, Teti G, Gasperi M, Murru S, Picchetti S, Bianchini P, Fioretti P
Clin Exp Obstet Gynecol. 1985;12(3-4):93-5.
The Authors studied the behaviour of anticomplement and heparin-like activities in human term placentas in relation to intrauterine fetal growth retardation. These two biological activities might be involved in regulatory mechanisms of great importance for the fetal growth. The anticomplement activity was significantly lower in IUGR placentas than in controls, while no change was found in heparin-like activity. The decrease of anticomplement activity might be associated to immunological mechanisms, possibly related to a placental microcirculation damage, with consequent fetal growth retardation. For what concerns HCS and E3 plasma levels during pregnancy, a significant reduction of HCS in IUGR subjects was observed, confirming a decreased functional activity of placenta. The E3 levels, on the contrary, were slightly, but not significantly lower in IUGR patients.
作者研究了足月人胎盘抗补体活性和类肝素活性与宫内胎儿生长受限的关系。这两种生物活性可能参与了对胎儿生长至关重要的调节机制。抗补体活性在宫内生长受限胎盘组中显著低于对照组,而类肝素活性未发现变化。抗补体活性的降低可能与免疫机制有关,可能与胎盘微循环损伤有关,从而导致胎儿生长受限。关于孕期血清人绒毛膜促性腺激素(HCS)和雌三醇(E3)血浆水平,观察到宫内生长受限患者的HCS显著降低,证实胎盘功能活性降低。相反,宫内生长受限患者的E3水平略有降低,但不显著。